L-Glutamine Oral Therapy Reduces Sickle Cell-Related Pain Better Than Placebo

Oral L-glutamine therapy significantly reduces pain crises associated with sickle cell disease compared with placebo regardless of patient hydroxyurea use, according to a study published in the New England Journal of Medicine. A multicenter, randomized …

Date : 2018-07-25T13:18:00.000Z
Source : https://www.clinicaladvisor.com/hematology/l-glutamine-reduces-pain-crises-in-sickle-cell-disease/article/782866/

1 thought on “L-Glutamine Oral Therapy Reduces Sickle Cell-Related Pain Better Than Placebo”

Leave a Comment